Video Latest - ecancer

KRAS in the clinic and conference

Dr Ana Vivancos - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

9 Oct 2016

Phase I results of a novel FGFR inhibitor

Dr Markus Joerger - Kantonsspital St. Gallen, St. Gallen, Switzerland

9 Oct 2016

Firstline pembrolizumab for metastatic urothelial cancer

Dr Arjun Balar - NYU Langone Medical Center, New York, USA

9 Oct 2016

Adjuvant cetuximab in the PETACC8 trial for stage III colon cancer

Prof Julien Taïeb - Georges Pompidou European Hospital, Paris, France

8 Oct 2016

FALCON trial: fulvestrant vs. anastrozole for HR advanced breast cancer

Prof John Robertson - University of Nottingham, Nottingham, UK

8 Oct 2016

Fulvestrant in FALCON trial improves PFS in advanced breast cancer

Dr Matthew Ellis - Washington University in St Louis, USA

8 Oct 2016

Dabrafenib shows higher response and lower toxicity in paediatric brain cancer trial

Dr Mark Kieran - Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, USA

8 Oct 2016

Ribociclib improves progression-free survival in advanced breast cancer

Prof Gabriel Hortobagyi - University of Texas MD Anderson Cancer Center, Houston, US

8 Oct 2016

Niraparib significantly improves outcomes for ovarian cancer patients

Dr Mansoor Raza Mirza - Rigshospitalet, Copenhagen University Hospital, Denmark

8 Oct 2016

Ipilimumab as adjuvant therapy improves OS in high risk melanoma

Prof Alexander Eggermont - Institut Gustave Roussy, Villejuif, France

8 Oct 2016

What is the impact of research within communities?

Ms Alexa Bishop - Cancer Research UK, UK

6 Oct 2016

Immunotherapy and treatment advances in small cell lung cancer

Prof Dean Fennell - University of Leicester, Leicester, UK

6 Oct 2016

Video